Tidal Vision completes $140M Series B to Scale Chitosan Technologies Globally

Funding Fuels Global Expansion with New Facilities that Strengthen Supply of Chitosan Chemistries.

BELLINGHAM, Wash., Feb. 5, 2025 /PRNewswire/ -- Tidal Vision, a biotechnology company transforming critical industries with chitosan-based chemistries, announced the closing of an oversubscribed $140M Series B financing round. The round exceeded its original target due to demand from strategically aligned investors including Cambridge Companies SPG, Eni Next (the corporate venture arm of Eni S.p.A), Milliken & Company, KIRKBI Climate, Convent Capital, SWEN Capital Partners' Blue Ocean Fund, MBX Capital, Oman Investment Authority's IDO Investments, and more.

This financing fuels Tidal Vision's ability to continuously increase the performance, economics, and ease of adoption of chitosan-based solutions with greater production capacities and expanded research and development resources. The company is building new infrastructure in Europe, Texas, and Ohio, further expanding its footprint. Resources will also be invested in accelerating R&D in chitosan and adjacent technologies, adding to the company's already impressive intellectual property portfolio. With a greater number of both commercial-scale and R&D facilities around the world, Tidal Vision will make chitosan-based solutions more accessible to customers globally.

"We are thrilled to have these strategically aligned capital partners onboard and supportive of accelerating our mission," said Craig Kasberg, CEO of Tidal Vision. "We've already demonstrated it's possible to make our biomolecular solutions outcompete. Now, we're building infrastructure that'll allow us to better serve customers who operate in critical industries providing the clean water, agriculture production, and materials necessary for everyday life."

"We're pleased to have led this $140M Series B growth equity round for Tidal Vision," said Filipp Chebotarev, Managing Partner and Chief Operating Officer at Cambridge Companies SPG. "Tidal Vision is the global leader in chitosan extraction, modification, characterization, and commercial applications. These important investments will enable Tidal Vision to continue to apply these crucial scientific breakthrough technologies commercially across a variety of sectors."

About Tidal Vision: 
Tidal Vision is a global leader in scalable biomolecular solutions for critical industries, such as water treatment, agriculture, and material science. Our mission is to create positive and systemic environmental impact. We're building a world where chitosan-based technologies are more economical, better performing, and easier to adopt. We invite the leaders of modern industry to join us in creating systemic impact globally.

Learn more at www.TidalVision.com and on LinkedIn. 

View original content to download multimedia:https://www.prnewswire.com/news-releases/tidal-vision-completes-140m-series-b-to-scale-chitosan-technologies-globally-302369307.html

SOURCE Tidal Vision